Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Crime and madness at the opposite shores of the Adriatic: moral insanity in Italian and Croatian psychiatric discourses.

D'Alessio V, Čeč F, Karge H.

Acta Med Hist Adriat. 2017 Dec;15(2):219-252.

PMID:
29402114
2.

Radionuclide Therapy of Unresectable Tumors with AvidinOX and (90)Y-biotinDOTA: Tongue Cancer Paradigm.

Albertoni C, Leoni B, Rosi A, D'Alessio V, Carollo V, Spagnoli LG, van Echteld C, De Santis R.

Cancer Biother Radiopharm. 2015 Sep;30(7):291-8. doi: 10.1089/cbr.2015.1837. Epub 2015 Jul 13.

3.

Simultaneous display of two large proteins on the head and tail of bacteriophage lambda.

Pavoni E, Vaccaro P, D'Alessio V, De Santis R, Minenkova O.

BMC Biotechnol. 2013 Sep 30;13:79. doi: 10.1186/1472-6750-13-79.

4.

AvidinOX™ for tissue targeted delivery of biotinylated cells.

Nucera E, Nicoletti C, Chiapparino C, Pacello ML, D'Alessio V, Musarò A, De Santis R.

Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):239-46.

PMID:
22507336
5.

Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells.

Gellini M, Ascione A, Flego M, Mallano A, Dupuis ML, Zamboni S, Terrinoni M, D'Alessio V, Manara MC, Scotlandi K, Picci P, Cianfriglia M.

Curr Pharm Biotechnol. 2013;14(4):449-63.

PMID:
22335486
6.

Chemical linkage to injected tissues is a distinctive property of oxidized avidin.

De Santis R, Anastasi AM, Pelliccia A, Rosi A, Albertoni C, Verdoliva A, Petronzelli F, D'Alessio V, Serani S, Nuzzolo CA.

PLoS One. 2011;6(6):e21075. doi: 10.1371/journal.pone.0021075. Epub 2011 Jun 20.

7.

Therapeutic use of avidin is not hampered by antiavidin antibodies in humans.

Petronzelli F, Pelliccia A, Anastasi AM, Lindstedt R, Manganello S, Ferrari LE, Albertoni C, Leoni B, Rosi A, D'Alessio V, Deiana K, Paganelli G, De Santis R.

Cancer Biother Radiopharm. 2010 Oct;25(5):563-70. doi: 10.1089/cbr.2010.0797. Epub 2010 Sep 23.

PMID:
20863248
8.

Anti-proliferative effect of a triazole derivative (ST1959) on LNCaP human prostate cancer cells through down-regulation of cyclin and androgen receptor expression.

Loiarro M, Campo S, Arseni B, Rossi S, D'Alessio V, De Santis R, Sette C, Ruggiero V.

Prostate. 2011 Jan 1;71(1):32-41. doi: 10.1002/pros.21219.

PMID:
20607765
9.

OXavidin for tissue targeting biotinylated therapeutics.

De Santis R, Albertoni C, Rosi A, Leoni B, Petronzelli F, D'Alessio V, Nucera E, Salvatori G, Paganelli G, Verdoliva A, Carminati P, Nuzzolo CA.

J Biomed Biotechnol. 2009;2009:921434. doi: 10.1155/2009/921434. Epub 2010 Jan 10.

10.

Structural characterization of the transmembrane proximal region of the hepatitis C virus E1 glycoprotein.

Spadaccini R, D'Errico G, D'Alessio V, Notomista E, Bianchi A, Merola M, Picone D.

Biochim Biophys Acta. 2010 Mar;1798(3):344-53. doi: 10.1016/j.bbamem.2009.10.018. Epub 2009 Nov 3.

11.

The immunosuppressor st1959, a 3,5-diaryl-s-triazole derivative, inhibits T cell activation by reducing NFAT nuclear residency.

Lindstedt R, Ruggiero V, D' Alessio V, Manganello S, Petronzelli F, Stasi MA, Vendetti S, Assandri A, Carminati P, De Santis R.

Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):29-42.

PMID:
19309550
12.

Efficacy of a nanocochleate-encapsulated 3,5-diaryl-s-triazole derivative in a murine model of graft-versus-host disease.

Campo S, Arseni B, Rossi S, D'Alessio V, Lu R, Ngoje J, Ahl PL, Bonitz S, Mannino R, Di Mitri D, Battistini L, Carminati P, De Santis R, Ruggiero V.

Transplantation. 2008 Jul 15;86(1):171-5. doi: 10.1097/TP.0b013e31817ba761.

PMID:
18622296
13.

Tumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells.

Pavoni E, Monteriù G, Santapaola D, Petronzelli F, Anastasi AM, Pelliccia A, D'Alessio V, De Santis R, Minenkova O.

BMC Biotechnol. 2007 Oct 18;7:70.

14.

Low and high tenascin-expressing tumors are efficiently targeted by ST2146 monoclonal antibody.

De Santis R, Albertoni C, Petronzelli F, Campo S, D'Alessio V, Rosi A, Anastasi AM, Lindstedt R, Caroni N, Arseni B, Chiodi P, Verdoliva A, Cassani G, Chinol M, Paganelli G, Carminati P.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2191-6.

15.

Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.

Pavoni E, Flego M, Dupuis ML, Barca S, Petronzelli F, Anastasi AM, D'Alessio V, Pelliccia A, Vaccaro P, Monteriù G, Ascione A, De Santis R, Felici F, Cianfriglia M, Minenkova O.

BMC Cancer. 2006 Feb 24;6:41.

16.

Improved tumor targeting by combined use of two antitenascin antibodies.

Petronzelli F, Pelliccia A, Anastasi AM, D'Alessio V, Albertoni C, Rosi A, Leoni B, De Angelis C, Paganelli G, Palombo G, Dani M, Carminati P, De Santis R.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7137s-7145s.

17.

Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT).

De Santis R, Anastasi AM, D'Alessio V, Pelliccia A, Albertoni C, Rosi A, Leoni B, Lindstedt R, Petronzelli F, Dani M, Verdoliva A, Ippolito A, Campanile N, Manfredi V, Esposito A, Cassani G, Chinol M, Paganelli G, Carminati P.

Br J Cancer. 2003 Apr 7;88(7):996-1003.

18.

Ethnic minorities: running a band-aid service.

D'Alessio V.

Nurs Stand. 1995 Jan 25-31;9(18):22-3. No abstract available.

PMID:
7888345
19.

The water poverty trap.

D'Alessio V.

Nurs Times. 1994 Jun 22-28;90(25):14-5. No abstract available.

PMID:
8029068
20.

Culture clash.

D'Alessio V.

Nurs Times. 1993 Sep 22-28;89(38):16-7. No abstract available.

PMID:
8415071
21.

[Active specific immunotherapy of cancer using anti-idiotypic monoclonal antibodies].

Castello G, D'Alessio V.

Clin Ter. 1991 May 15;137(3):155-67. Review. Italian.

PMID:
1831084
22.

Urinary neopterin and immunological features in patients with Kaposi's sarcoma.

Santelli G, Melillo G, Marfella A, Napolitano M, D'Alessio V, Satriano RA, Beth-Giraldo E, Giraldo G, Perna M, Castello G.

Eur J Cancer Clin Oncol. 1988 Sep;24(9):1391-6.

PMID:
3263274
23.

Immunologic abnormalities in patients with chronic delta infection.

Castello G, Ciampi R, Leonardi E, Abrescia N, Ronga D, D'Alessio V.

Boll Ist Sieroter Milan. 1988;67(5-6):337-44.

PMID:
2908737
24.

Relationship between immunodeficiency conditions and AIDS-associated retrovirus (ARV) infection in homosexual men and i.v. drug abusers in the Campania Region.

Castello G, Melillo G, D'Alessio V, Leonardi E, Zarrilli D, Cataldo PT, Chirianni A, de Mercato R, Piazza M.

Haematologica. 1986 Nov-Dec;71(6):453-7. No abstract available.

PMID:
3104152
25.

The 2,2'-dicyano-1,1'-dimethyl-4,4'-bipyridylium di-cation: a viologen indicator with a high redox potential.

Ballio A, Casinovi CG, D'Alessio V, Grandolini G, Randazzo G, Rossi C.

Experientia. 1974 Aug 15;30(8):843-4. No abstract available.

PMID:
4416617

Supplemental Content

Loading ...
Support Center